Stock Movers Adobe Falls, Peloton Drops, Hims & Hers Health Mixed As Shares Set for Record Week
Mar 13, 2026
A rundown of a major tech leader stepping down and the market worries that follow. Coverage of a fitness company shifting toward treadmills and cheaper models. A health firm’s stock surge tied to a new weight-loss drug partnership and the legal and deal risks behind it.
AI Snips
Chapters
Transcript
Episode notes
Adobe CEO Exit Raises AI Era Doubts
- Adobe's CEO Shantanu Narayen will resign, sparking market concern despite solid earnings.
- Analysts say the exit raises questions about strategic continuity and Adobe's ability to compete in the AI era, pressuring the stock down ~7% that day.
Peloton Shifts Toward Treadmills And AI
- Peloton plans to prioritize treadmills, add lower-priced models, and expand AI-driven training features.
- These product changes aim at strength training insights and personalized plans but are at least a year away, limiting near-term upside.
Hims Partners With Novo Nordisk For GLP-1 Access
- Hims & Hers struck a partnership with Novo Nordisk to sell Novo's weight-loss drugs, fueling a ~53% rally this week.
- The deal stops advertising compounded copycats and follows prior legal disputes with Novo, so durability of the arrangement matters.